Are ICU patients getting the right antibiotic dose? new study aims to find out
NCT ID NCT07287813
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether standard antibiotic doses are effective for ICU patients on ECMO (heart-lung support) or kidney dialysis. Researchers will measure drug levels in 40 adults with serious infections. The goal is to see if dosing adjustments are needed to avoid under- or over-treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- beta-lactam antibiotics and beta-lactamase inhibitors
- What this could lead to
- If successful, this could help doctors give the right antibiotic doses to critically ill patients on life support, improving infection treatment and reducing side effects.
- What could go wrong
- This is a small, early-stage observational study with only 40 patients. It does not test a new treatment, so results may not change practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICU PATIENTS WITH ECMO AND-OR RRT AND WITH GRAM NEGATIVE INFECTIONS SUSCEPTIBLE TO BL-BLIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy, 27100, Italy